This company is no longer in business. Investors can get details about any potential exits or failures here.

Ionica Sciences

Ionica Sciences

Early Stage

A better way to test for Lyme disease

A better way to test for Lyme disease

Overview

Raised to Date: Raised: $0

Total Commitments ($USD)

Platform

SeedInvest

Start Date

09/09/2020

Close Date

11/08/2020

Min. Goal
$25,000
Max. Goal
$750,000
Min. Investment

$1,000

Security Type

Convertible Note

Series

Seed

SEC Filing Type

RegCF / RegD 506(c)    Open SEC Filing

Valuation Cap

$5,500,000

Discount

20%

Rolling Commitments ($USD)

Status
Not Funded
Reporting Date

11/07/2020

Days Remaining
Not Funded
% of Min. Goal
Not Funded
% of Max. Goal
Not Funded
Likelihood of Max
Not Funded
Avg. Daily Raise

$0

Momentum
Not Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded

2013

Industry

Healthcare & Pharmaceuticals

Tech Sector

Medtech

Distribution Model

B2B2C

Margin

Medium

Capital Intensity

High

Location

Ithaca, New York

Business Type

Growth

Ionica Sciences, with a $5.5 million valuation cap, is raising crowdfunding on SeedInvest. The company’s technology enables direct detection of Lyme disease with the help of a blood test. Lyme disease is difficult to diagnose, but it becomes easily detectable with the IonLyme Test of Ionica Sciences. The test detects a special protein released into the blood by the bacteria causing the disease. Omar Green, Joel Tabb, and Dean Koch founded Ionica Sciences in 2013. The proceeds of the current crowdfunding round, with a minimum raise of $25,000 and a maximum raise of $750,000, will be used for salaries, research and development, operations, and commercial lab transfer. Ionica Sciences has filed an international patent application under the PCT and received three SBIR contracts from the Department of Defense and the Defense Health Agency.

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$0

$0

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$-325,300

$-40,643

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$139,160

$300,890

Accounts Receivable

$0

$0

Total Assets

$232,502

$375,663

Short-Term Debt

$293,928

$43,544

Long-Term Debt

$0

$225,000

Total Liabilities

$293,928

$268,544

Financials as of: 09/09/2020
Create a free account today to gain access to KingsCrowd analytics.

Funding data not publicly available

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
Ionica Sciences on SeedInvest
Platform: SeedInvest
Security Type: Convertible Note
Valuation: $5,500,000

Follow company

Follow Ionica Sciences on SeedInvest

Buy Ionica Sciences's Deal Report

Warning: according to the close date for this deal, Ionica Sciences may no longer be accepting investments.

Ionica Sciences Deal Report

Get KingsCrowd’s comprehensive report on Ionica Sciences including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Ionica Sciences is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Ionica Sciences deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge